Access in all areas? A round up of developments in market access and health technology assessment: part 9 Journal of Comparative Effectiveness Research. 2025;14(10):e250120
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40767045

Access in all areas? A round-up of developments in market access and health technology assessment: part 10  Journal of Comparative Effectiveness Research. 2025:e250138
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40955618

Artificial intelligence in key pricing, reimbursement, and market access (PRMA) processes: better, faster, cheaper-can you really pick two?  Journal of Medical Economics. 2025;28(1):586–595
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40167461

Composite endpoints in health technology assessment: Part 1 - an illustration of best modeling practice  Journal of Comparative Effectiveness Research. 2025;14(10):e240117
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40927977

Composite endpoints in health technology assessment: Part 2 - expanding the evidence base with a framework for best modeling practice  Journal of Comparative Effectiveness Research. 2025;14(10):e250012
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40927978

Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective  Pharmacoeconomics. 2025;43(10):1165–1169
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40699293

Early health technology assessment: current and future perspectives from a health technology assessment agency  International Journal of Technology Assessment in Health Care. 2025;41(1):e68
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40958666

Early-stage assessment of investigational digital technologies in mental health: a guide for innovators  Psychiatry Research. 2025;351:116634
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40743859

European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example  J Mark Access Health Policy. 2025;13(3):42
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40989744

FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making Clinical Pharmacology and Therapeutics. 2025;118(3):649–661
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40493357

A Framework for Considering the Role of the Public Sector in R&D of Health Technology  Pharmaceutical Medicine. 2025;39(5):325–340
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40779237

HTA Evidence in Rare Diseases: Just Rare or Also Special?  Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40924270

Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study  Pharmacoeconomics. 2025;43(10):1205–1222
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40682640

Is Innovation Worth the Price? Cost-Effectiveness Analysis in Interventional Oncology  Cardiovascular and Interventional Radiology. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41016947

Personalised exercise-rehabilitation for people with multiple long-term conditions (PERFORM): a randomised feasibility study  BMJ Open. 2025;15(9):e100195
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40967655

The PICO Puzzle: Can Public Data Predict EU HTA Expectations for All EU Countries?  J Mark Access Health Policy. 2025;13(3):32
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40709217

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20  Journal of Comparative Effectiveness Research. 2025;14(9):e250113
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40698536

Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer  Journal of Comparative Effectiveness Research. 2025;14(10):e250041
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40836909

Use of real-world data and real-world evidence in NICE (UK) health technology appraisals of new therapeutics in oncology: a systematic review  BMJ Open. 2025;15(9):e102769
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41022438

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease  EClinicalMedicine. 2025;88:103465
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40932851

Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries  Health Econ Policy Law. 2025;20(3):264–283
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40922553